A detailed history of Ancora Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ancora Advisors, LLC holds 35,692 shares of AMGN stock, worth $9.44 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
35,692
Previous 36,108 1.15%
Holding current value
$9.44 Million
Previous $11.3 Million 1.94%
% of portfolio
0.28%
Previous 0.3%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $128,702 - $140,350
-416 Reduced 1.15%
35,692 $11.5 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $130,324 - $158,377
-496 Reduced 1.36%
36,108 $11.3 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $246,016 - $296,972
-915 Reduced 2.44%
36,604 $10.4 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $155,209 - $175,095
-607 Reduced 1.59%
37,519 $10.8 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $114,791 - $142,516
-525 Reduced 1.36%
38,126 $10.2 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $299,120 - $353,704
-1,396 Reduced 3.49%
38,651 $8.58 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $205,694 - $250,707
-911 Reduced 2.22%
40,047 $9.68 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $224,449 - $285,189
-980 Reduced 2.34%
40,958 $10.8 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $55,666 - $62,781
-248 Reduced 0.59%
41,938 $9.45 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $190,566 - $212,067
-826 Reduced 1.92%
42,186 $10.3 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $18.5 Million - $20.4 Million
-84,218 Reduced 66.19%
43,012 $10.4 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $17.8 Million - $19.7 Million
81,299 Added 177.0%
127,230 $31.7 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $503,564 - $576,283
-2,532 Reduced 5.22%
45,931 $10.3 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $15.4 Million - $18 Million
-72,360 Reduced 59.89%
48,463 $10.3 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $1.5 Million - $1.66 Million
-6,407 Reduced 5.04%
120,823 $29.5 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $302,019 - $351,954
-1,361 Reduced 1.06%
127,230 $31.7 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $745,429 - $887,673
-3,445 Reduced 2.61%
128,591 $29.6 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $383,887 - $426,914
1,636 Added 1.25%
132,036 $33.6 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $623,892 - $765,601
3,154 Added 2.48%
130,400 $30.8 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $2.09 Million - $2.77 Million
11,441 Added 9.88%
127,246 $25.8 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $4.16 Million - $5.35 Million
21,997 Added 23.45%
115,805 $27.9 Million
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $975,364 - $1.17 Million
5,602 Added 6.35%
93,808 $18.2 Million
Q2 2019

Aug 12, 2019

BUY
$166.7 - $195.41 $879,342 - $1.03 Million
5,275 Added 6.36%
88,206 $16.3 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $15 Million - $16.9 Million
82,931 New
82,931 $15.8 Million
Q4 2018

Feb 15, 2019

SELL
$178.4 - $208.25 $4.1 Million - $4.79 Million
-23,003 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $94,312 - $106,325
509 Added 2.26%
23,003 $4.77 Million
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $307,524 - $345,416
1,852 Added 8.97%
22,494 $4.15 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $3.5 Million - $4.09 Million
20,642 New
20,642 $3.52 Million
Q4 2017

Feb 14, 2018

SELL
$168.79 - $188.59 $2.51 Million - $2.8 Million
-14,856 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $2.49 Million - $2.84 Million
14,856
14,856 $2.77 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.